Bristol Myers Squibb - Melanoma in 2020: Reflect, reset, and continue
Emerging long-term survival data and implications for clinical practice
Date
14 Sep 2020Session
Bristol Myers Squibb - Melanoma in 2020: Reflect, reset, and continuePresenters
Pippa CorrieAuthors
P. CorrieAuthor affiliations
- Department Of Oncology, Addenbrookes Hospital, Cambridge University Hospitals NHS Foundation Trust, CB2 0QQ - Cambridge/GB
Resources
Resources from the same session
Welcome and Introduction
Presenter: James Larkin
Session: Bristol Myers Squibb - Melanoma in 2020: Reflect, reset, and continue
Resources:
Webcast
Expert insights: Adapting treatment during the COVID-19 pandemic
Presenter: Pippa Corrie
Session: Bristol Myers Squibb - Melanoma in 2020: Reflect, reset, and continue
Resources:
Webcast
Studying survival: An evidence-based approach to improving outcomes
Presenter: Paolo Ascierto
Session: Bristol Myers Squibb - Melanoma in 2020: Reflect, reset, and continue
Resources:
Webcast
Summary and close
Presenter: James Larkin
Session: Bristol Myers Squibb - Melanoma in 2020: Reflect, reset, and continue
Resources:
Webcast
Live Q&A - 23 September 2020 - 10:00-10:30
Presenter: James Larkin
Session: Bristol Myers Squibb - Melanoma in 2020: Reflect, reset, and continue
Resources:
Webcast
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
-
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.